SCHEMBL18200434

SCHEMBL18200434

c1ccc(-c2cccc(-c3cc(-c4ccc(-c5nc6ccccc6c6c5ccc5ccccc56)cc4)nc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
MAPT P10636 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 4/20 0.43
KDM4E B2RXH2 3/20 0.43
LMNA P02545 3/20 0.43
ATM Q13315 1/20 0.43
GLA P06280 1/20 0.43
PTGES O14684 1/20 0.41
NTSR1 P30989 1/20 0.41
DHODH Q02127 2/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
ACHE P22303 1/20 0.38
NQO2 P16083 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18201108 1.00 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18201272 1.00 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18201109 1.00 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18201107 1.00 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18200942 1.00 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18201098 1.00 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18200938 0.99 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18201102 0.99 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18201140 0.99 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18200632 0.99 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MEN1 1750/4885KMT2A 1104/4885MAPT 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.